Clinical utility of the systemic inflammatory response (SIR) in identifying high-risk stage II colon cancer.

Authors

null

Allan Matthew Golder

Academic Unit of Surgery, Glasgow, United Kingdom

Allan Matthew Golder , Donald C. McMillan , David Mansouri , Paul G. Horgan , Campbell SD Roxburgh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Anal and Colorectal Cancer

Track

Colorectal Cancer,Anal Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 220)

Abstract #

220

Poster Bd #

K20

Abstract Disclosures

Similar Posters

Poster

2020 Gastrointestinal Cancers Symposium

The potential for combined measures of the systemic inflammatory response (SIR) in colon cancer: An analysis of 2,300 patients.

The potential for combined measures of the systemic inflammatory response (SIR) in colon cancer: An analysis of 2,300 patients.

First Author: Allan Matthew Golder

First Author: Allan Matthew Golder

First Author: Zehua Wu